Akebia Therapeutics, Inc. (AKBA)
1.44
+0.07
(+5.11%)
USD |
NASDAQ |
Jan 22, 16:00
1.45
+0.01
(+0.69%)
After-Hours: 20:00
Akebia Therapeutics Cash from Investing (Quarterly): -0.077M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Amgen, Inc. | -414.00M |
| Pfizer Inc. | -2.43B |
| Theravance Biopharma, Inc. | -100.25M |
| Zevra Therapeutics, Inc. | -4.576M |
| Organon & Co. | -115.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 28.10M |
| Cash from Financing (Quarterly) | 1.113M |
| Free Cash Flow | 32.17M |
| Free Cash Flow Per Share (Quarterly) | 0.1022 |
| Free Cash Flow to Equity (Quarterly) | 25.29M |
| Free Cash Flow to Firm (Quarterly) | 30.25M |
| Free Cash Flow Yield | 8.89% |